Investor mix
4 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 2 | 50% |
| Other / undisclosed | 2 | 50% |
Developing monoclonal antibody-based therapeutics for cancer-associated diseases.
4 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 2 | 50% |
| Other / undisclosed | 2 | 50% |